Emergency & Toxicology

Salicylate toxicity: recognition and management

Clinical Overview and When to Suspect Salicylate Toxicity

— Direct stimulation of medullary respiratory center → primary respiratory alkalosis

— Uncoupling of oxidative phosphorylation → heat, lactate, ketones → anion gap metabolic acidosis

— Classic adult ABG: mixed respiratory alkalosis + anion gap metabolic acidosis with near-normal or alkalemic pH

— Children and late-presenting adults more often show pure acidosis (worse prognosis)

— Tinnitus + tachypnea + nausea in an arthritis patient on chronic ASA

— Elderly nursing home patient with confusion, hyperventilation, low-grade fever, dehydration — chronic salicylism is frequently misdiagnosed as sepsis or delirium

— Suicidal ingestion with hyperpnea, vomiting, diaphoresis

— Toddler who ingested topical wintergreen oil or methyl salicylate liniment

— Any unexplained mixed acid-base disorder with high anion gap

— Acute: known ingestion, levels correlate with severity, Done nomogram historically used (now discouraged — trend levels and clinical picture)

— Chronic: lower serum levels (often 30–60 mg/dL) but more CNS toxicity and higher mortality because tissue/CNS levels exceed serum

Definition: Acute or chronic poisoning from aspirin (ASA), oil of wintergreen (methyl salicylate — one teaspoon ≈ 7 g ASA), bismuth subsalicylate, topical salicylate creams, or Pepto-Bismol overuse. Toxic dose acute ingestion: >150 mg/kg or >6.5 g.

Pathophysiology pearls:

When to suspect on the boards/CCS:

Acute vs chronic:

Board pearl: A normal or only mildly elevated salicylate level in a confused, hyperventilating elderly patient does not rule out toxicity — chronic toxicity occurs at lower levels and demands the same aggressive treatment.

Step 3 management priority: Recognition is the rate-limiting step; once suspected, simultaneously check level, ABG/VBG, glucose, lactate, and prepare for urinary alkalinization and possible hemodialysis rather than waiting for confirmation.

Presentation Patterns and Key History

— Tinnitus, decreased hearing, vertigo

— Nausea, vomiting, epigastric pain, hematemesis (gastric irritation)

— Hyperpnea and tachypnea (deep, sighing Kussmaul-like breathing from respiratory center stimulation, not just acidosis)

— Diaphoresis, flushing, low-grade fever

— Agitation, confusion, hallucinations, slurred speech

— Hyperthermia (uncoupling) — ominous sign

— Volume depletion from insensible losses, vomiting, tachypnea

— Hypoglycemia (CNS glucose may be low despite normal serum)

— Seizures, coma, cerebral edema

— Non-cardiogenic pulmonary edema (ARDS), especially in chronic and elderly

— Cardiovascular collapse, dysrhythmia from acidemia and hypokalemia

— Elderly on ASA for CAD/AF, often with new NSAID or dehydrating illness

— Insidious confusion, dyspnea, weakness; frequently mistaken for pneumonia, sepsis, CHF, or dementia

— Often presents with normal mentation initially then rapid decompensation

— Exact product, formulation (enteric-coated/sustained-release prolong absorption), quantity, time

— Co-ingestants (acetaminophen — always check level; alcohol; benzodiazepines)

— Topical exposures (methyl salicylate ointments — Bengay, IcyHot — in athletes/elderly)

— Prior chronic ASA dose, recent dose escalation, recent illness or AKI

— Pregnancy status (salicylates cross placenta and concentrate in fetus)

Early acute toxicity (1–6 h post-ingestion):

Moderate/severe acute (6–24 h):

Late/severe:

Chronic salicylism:

Key history questions (CCS-style):

Key distinction: Tinnitus and hyperventilation in an adult on chronic aspirin = chronic salicylate toxicity until proven otherwise, even with a "therapeutic" level.

Board pearl: Enteric-coated and sustained-release ASA can produce delayed peak levels at 12–24 h or longer. Serial levels every 2 h until they peak and fall are mandatory — a single low level is meaningless.

Physical Exam Findings and Hemodynamic Assessment

— Tachypnea/hyperpnea — out of proportion to acidosis

— Hyperthermia — uncoupling oxidative phosphorylation; correlates with severity

— Tachycardia — volume depletion, catecholamine drive

— Hypotension late — capillary leak, ARDS, acidemia-induced vasodilation

— Tinnitus (subjective, near-universal in awake adults)

— Reduced auditory acuity

— Dry mucous membranes

— Deep, rapid respirations with clear lungs early

— Crackles, hypoxia, frothy sputum → non-cardiogenic pulmonary edema/ARDS (more common in chronic, elderly, smokers, severe poisoning)

— Mild: anxious, restless, tinnitus

— Moderate: confusion, lethargy, slurred speech

— Severe: stupor, seizures, coma — CNS findings = CNS salicylate penetration = hemodialysis indication

— Always check fingerstick glucose — neuroglycopenia can occur with normal serum glucose

— Epigastric tenderness, hematemesis from gastritis

— Diaphoresis, flushed warm skin

— Petechiae/bleeding (platelet dysfunction, hypoprothrombinemia)

— Patients are typically severely volume-depleted (1–2 L deficit) from vomiting, hyperventilation, fever, and renal losses

— Orthostasis, poor turgor, flat neck veins

Vital signs (classic tetrad):

HEENT:

Pulmonary:

Neurologic — the single most important exam:

GI/Skin:

Volume assessment:

Step 3 management: Aggressive isotonic fluid resuscitation early (LR or NS) — euvolemia is required for renal salicylate elimination and to permit urinary alkalinization. However, watch for pulmonary edema and cerebral edema — titrate carefully in elderly and chronic toxicity.

CCS pearl: Order continuous cardiac monitoring, pulse oximetry, frequent neuro checks every 1 h, and a Foley to track urine output and pH. Mental status deterioration is the trigger to escalate to dialysis — do not wait for the level.

Diagnostic Workup — Initial Labs, ABG, ECG

— Serum salicylate level (mg/dL) — repeat every 2 h until peak identified and trending down; therapeutic 10–30, toxic >40, severe >80–100 acute, >60 chronic

— Acetaminophen level — mandatory in any intentional ingestion

— ABG or VBG with co-oximetry — characterize acid-base

— BMP — anion gap, K+, HCO3-, BUN/Cr, glucose

— Lactate, ketones (BHB) — contribute to anion gap

— CBC, coags (PT/INR), LFTs

— Urinalysis with urine pH — baseline before alkalinization; ferric chloride turns purple (qualitative)

— Pregnancy test, ethanol level, drug screen

— Adult: pH 7.40–7.50, PaCO2 ~20–25, HCO3 ~15–18, AG 18–25 → mixed primary respiratory alkalosis + anion gap metabolic acidosis

— Child or late/severe adult: pH <7.35 with HCO3 <12 — pure or predominant acidosis, higher mortality

— Acidemia (pH <7.40) in salicylate toxicity is dangerous because it shifts salicylate from ionized to non-ionized form → enhanced CNS penetration

— Sinus tachycardia

— Findings of hypokalemia (U waves, flattened T) from renal K+ loss during alkalinization

— QT prolongation, dysrhythmia in severe cases

— CXR if hypoxia, tachypnea out of proportion, crackles → assess for ARDS

— Head CT if altered mental status to exclude alternative causes before assuming salicylism

Send immediately on suspicion:

Classic ABG patterns:

ECG:

Imaging:

Board pearl: A salicylate-poisoned patient who becomes "tired of breathing," whose respiratory rate falls and PaCO2 rises, is on the brink of catastrophic decompensation — pH crashes, salicylate floods CNS. Do not intubate casually; if you must, match their pre-intubation minute ventilation and alkalinize aggressively.

Key distinction: Anion gap with mixed alkalosis-acidosis pattern in an adult differentiates salicylates from pure DKA, methanol, or ethylene glycol (which typically present with isolated acidosis).

Diagnostic Workup — Advanced and Confirmatory Studies

— Every 2 h until two consecutive levels fall and clinical improvement

— Especially critical for enteric-coated/sustained-release ASA, bezoar formation, pylorospasm

— Levels must be interpreted with pH — a level of 50 mg/dL with pH 7.20 is far more dangerous than 80 mg/dL with pH 7.45 (acidemia drives CNS uptake)

— Historically used for acute ingestion timing/severity

— No longer recommended — does not apply to chronic toxicity, enteric-coated formulations, or sustained-release; clinical picture trumps level

— Bedside urine ferric chloride test (purple = salicylate present; qualitative only)

— Urine pH monitoring every 1 h during alkalinization (goal 7.5–8.0)

— Serum K+ every 1–2 h — hypokalemia prevents urinary alkalinization

— APAP level at 4 h (or stat if unknown timing) plotted on Rumack-Matthew

— Osmolar gap if toxic alcohol concern

— Lactate, beta-hydroxybutyrate to parse anion gap contributors

— CXR for ARDS, aspiration

— Non-contrast head CT if persistent altered mentation, focal deficits, or pre-intubation — rule out cerebral edema, hemorrhage (salicylates cause platelet dysfunction)

— Baseline Cr crucial — AKI worsens salicylate retention and is an indication for hemodialysis

— LFTs may be mildly elevated; significant elevation suggests co-ingestion or alternate diagnosis

Serial salicylate levels — the cornerstone:

Beware the Done nomogram:

Confirmatory adjuncts:

Differentiating co-ingestion:

Imaging for complications:

Renal and hepatic assessment:

CCS pearl: Order recurring labs in advance — "salicylate level q2h, BMP q4h, ABG q4h, urine pH q1h" — the simulation rewards anticipating trajectory. Recheck level after dialysis because rebound from tissue redistribution is common; a second run may be required.

Board pearl: A rising salicylate level after GI decontamination should raise suspicion for pharmacobezoar from massive enteric-coated ingestion — consider whole-bowel irrigation and repeat-dose activated charcoal.

Risk Stratification and First-Line Management Logic

— Mild: awake, tinnitus only, level <40, normal pH, normal renal function → ED observation, supportive care, possible single-dose charcoal if <1–2 h post-ingestion

— Moderate: level 40–80, mixed acid-base disturbance, GI symptoms, mild CNS changes → admit to monitored bed/step-down, urinary alkalinization, serial labs

— Severe: level >80 acute or >60 chronic, altered mentation, seizure, pulmonary/cerebral edema, AKI, pH <7.20, hemodynamic instability → ICU + hemodialysis

— Altered mental status

— ARDS requiring oxygen

— Cerebral edema

— Renal failure impairing excretion

— Severe acidemia (pH ≤7.20)

— Salicylate level >100 mg/dL acute or >90 with renal impairment

— Chronic level >60 mg/dL with symptoms

— Failure to improve despite optimal supportive care/alkalinization

— Inability to tolerate alkalinization (e.g., volume overload)

1. ABCs; protect airway but avoid intubation if possible

2. Two large-bore IVs; isotonic fluids 10–20 mL/kg bolus then maintenance

3. Fingerstick glucose; D50 if low or if altered mental status (give empirically)

4. Activated charcoal 1 g/kg PO/NG if alert, <1–2 h post-ingestion, no contraindication

5. Send labs and serial monitoring plan

6. Initiate sodium bicarbonate infusion (see chunk 7)

7. Replete potassium aggressively

8. Call Poison Control (1-800-222-1222) and nephrology for possible dialysis

Severity tiers guide disposition and dialysis:

EXTRIP/AACT criteria for hemodialysis (memorize):

Sequence of care (first 60 minutes):

Step 3 management: Disposition is driven less by absolute level and more by clinical trajectory + acid-base + end-organ involvement. An asymptomatic patient with a falling level can go to step-down; a confused chronic-toxicity patient with level 55 needs ICU and likely dialysis.

Board pearl: Decision to dialyze is clinical — never delay HD waiting on a "higher" level when the patient is confused, acidemic, or has pulmonary/cerebral edema.

Pharmacotherapy — First-Line Regimen

— Goal 1: Serum pH 7.45–7.55 (reduces CNS penetration by keeping salicylate ionized)

— Goal 2: Urine pH 7.5–8.0 (ion-traps salicylate, enhances renal elimination 5–20×)

— Bolus: 1–2 mEq/kg IV push of 8.4% NaHCO3

— Infusion: 3 amps (150 mEq) NaHCO3 in 1 L D5W, run at 1.5–2× maintenance (typically 150–250 mL/h)

— Recheck serum and urine pH every 1 h

— Hypokalemia is the #1 reason urinary alkalinization fails — kidneys reabsorb K+ in exchange for H+, acidifying urine

— Add 20–40 mEq KCl per liter of bicarbonate infusion once urine output established

— Keep serum K+ ≥4.0 mEq/L

— D5 in the bicarbonate infusion

— Empiric dextrose for any altered mental status — CNS glucose may be low despite normal serum glucose

— 1 g/kg PO/NG if airway protected and within ~2 h (consider longer for enteric-coated/sustained-release)

— Multi-dose activated charcoal (MDAC): every 4 h for large ingestion or sustained-release — adsorbs enterohepatically recirculated salicylate

— Acetazolamide (alkalinizes urine but worsens systemic acidosis — contraindicated)

— Excessive sedation/opioids — depress respiratory drive

— Routine intubation — see chunk 8

— Initial volume resuscitation, then maintenance at 1.5–2 mL/kg/h

— Monitor for pulmonary and cerebral edema, especially elderly and chronic toxicity

Sodium bicarbonate — the cornerstone of non-dialytic management:

Potassium repletion — mandatory:

Glucose:

Activated charcoal:

Antiemetics: ondansetron preferred (avoid metoclopramide if QT concerns)

Avoid:

Fluid balance:

CCS pearl: Order set: "NS bolus 1 L; D5W + 3 amps NaHCO3 + 40 mEq KCl @ 200 mL/h; salicylate q2h; BMP q4h; urine pH q1h; glucose q1h; strict I/O; continuous cardiac monitor."

Board pearl: If urine pH won't rise despite bicarbonate, check potassium — replete first, then reassess.

Hemodialysis and Procedural Management

— Altered mental status (any)

— New hypoxemia requiring supplemental O2 (suggests ARDS)

— Acute level >100 mg/dL (or >90 with impaired kidney function)

— Chronic level >60 mg/dL with symptoms

— pH ≤7.20 despite optimal therapy

— Renal failure preventing excretion

— Cannot tolerate or fails sodium bicarbonate therapy (volume overload, refractory acidemia)

— Clinical deterioration despite maximal medical management

— Intermittent hemodialysis (IHD) preferred — highest clearance

— CRRT is inferior for salicylate; use only if hemodynamic instability prevents IHD, and consider running it at high flow rates

— May require a second run — rebound from intracellular/tissue redistribution is common

— Whole-bowel irrigation with PEG (1–2 L/h) for sustained-release/enteric-coated massive ingestion or suspected pharmacobezoar

— Endoscopy rarely needed

— Foley catheter for hourly urine pH and output

— Pre-intubation: maximize bicarbonate, correct K+, plan to match minute ventilation (these patients ventilate at 25–35/min with high tidal volumes)

— Ventilator settings: high RR (24–30), normal Vt — keep PaCO2 at patient's pre-intubation level

— Apnea during RSI = catastrophic pH drop, salicylate floods CNS, cardiac arrest

— If possible, bridge to dialysis without intubation; if intubation unavoidable, give bicarbonate push immediately before/during RSI and proceed to HD emergently

Hemodialysis is definitive therapy for severe salicylate toxicity — salicylate is small (138 Da), low volume of distribution (~0.2 L/kg), poorly protein-bound at high levels, and water-soluble → ideal for HD.

Indications (EXTRIP 2015 consensus):

Modality choice:

Adjunctive procedures:

Intubation — handle with extreme care:

Step 3 management: When you call nephrology, frame request as "salicylate toxicity meeting EXTRIP criteria — need emergent HD." Continue bicarbonate infusion up to and during HD setup.

CCS pearl: After HD, recheck salicylate level 1–2 h post; if rebound >40 or symptoms recur, request a second run.

Special Populations — Elderly and Renal/Hepatic Impairment

— Most deaths from salicylate toxicity occur in chronic toxicity in older adults

— Often misdiagnosed as sepsis, CHF exacerbation, pneumonia, delirium, or CVA

— Lower serum levels (40–60) cause severe CNS toxicity because of decreased plasma protein binding, reduced renal clearance, higher tissue distribution

— Threshold for hemodialysis is lower — symptomatic chronic toxicity with level >60 mg/dL warrants HD

— Dose escalation for arthritis pain

— New NSAID, ACEi, or diuretic causing AKI

— Dehydration (heat, gastroenteritis, diuresis)

— Drug interactions reducing clearance

— Salicylate excretion depends almost entirely on kidneys at toxic levels (saturated hepatic conjugation)

— Any AKI/CKD → rapid accumulation and lower threshold for HD

— Bicarbonate infusion still appropriate but watch for volume overload and hypernatremia; in oliguric patients, proceed to early HD

— Adjust fluid rate; consider central venous monitoring or POCUS for volume status

— Less critical than renal because metabolism is already saturated at toxic doses

— However, coagulopathy worsens GI bleeding risk and hypoprothrombinemia — consider vitamin K

— Warfarin + ASA → bleeding

— ACEi/ARB + NSAID + diuretic ("triple whammy") precipitates AKI and salicylism

— Carbonic anhydrase inhibitors (acetazolamide, topiramate) worsen acidosis — contraindicated in salicylate toxicity

Elderly — the high-mortality population:

Triggers for chronic toxicity in elderly:

Renal impairment:

Hepatic impairment:

Drug interactions to recognize:

Step 3 management: In any elderly patient with new confusion + tachypnea on chronic ASA, stop the aspirin, send a level, check ABG, and start workup before assuming a primary infectious or neurologic cause. Empiric salicylate evaluation costs nothing and saves lives.

Board pearl: Chronic salicylism in elderly = lower level, higher mortality, earlier dialysis — the inverse of intuitive level-based thinking.

Special Populations — Pregnancy and Pediatrics

— Salicylates cross the placenta and concentrate in the fetus because of fetal acidemia and lower protein binding

— Fetal salicylate levels exceed maternal at steady state

— Maternal alkalemia may mask severity; fetus may be acidemic and toxic even when mom looks stable

— Risks: premature closure of ductus arteriosus, fetal hemorrhage, stillbirth, kernicterus in neonate (displaces bilirubin from albumin), maternal hemorrhage

— Hemodialysis indications are more liberal in pregnancy; consult OB and nephrology early

— Delivery decision in late-term toxicity is individualized — fetal monitoring throughout

— Toddlers: small ingestions of oil of wintergreen are highly lethal (1 tsp ≈ 7 g ASA)

— Topical salicylate ointments (methyl salicylate, trolamine salicylate) cause systemic toxicity when applied liberally to broken skin or with heating pads

— Children present more often with pure metabolic acidosis rather than mixed picture — worse prognosis

— Hypoglycemia more common and more profound — check and treat aggressively

— Reye syndrome: ASA use in children with viral illness (varicella, influenza) → encephalopathy + hepatic failure — never give ASA to children for fever except Kawasaki disease

— Maternal late-pregnancy salicylate exposure → neonatal bleeding, metabolic acidosis, hypoglycemia

— Vitamin K and supportive care; HD rarely needed but feasible

— Intentional ingestion — psychiatric evaluation required prior to discharge

— Screen for co-ingestion (APAP, SSRIs, alcohol)

Pregnancy:

Pediatrics:

Neonates:

Adolescents:

Step 3 management: Pregnant patient with salicylate toxicity → continuous fetal monitoring, OB consult, lower threshold for HD, alkalinize aggressively, plan delivery if fetal distress or maternal deterioration.

Key distinction: A child with "unexplained" anion gap acidosis + hyperpnea + hypoglycemia should prompt salicylate level — wintergreen oil and grandparent's aspirin bottle are classic exposures.

Complications and Adverse Outcomes

— Cerebral edema — leading cause of death in severe toxicity

— Seizures (often from hypoglycemia, hyponatremia, or direct CNS effect)

— Coma, persistent encephalopathy

— Tinnitus and high-frequency hearing loss — usually reversible but can persist

— Non-cardiogenic pulmonary edema/ARDS — increased pulmonary capillary permeability; more common in chronic toxicity, elderly, smokers, severe acidemia

— Aspiration pneumonitis from vomiting and decreased mental status

— Respiratory failure if patient tires

— Hypotension from volume depletion and vasodilation

— Dysrhythmias from hypokalemia, acidemia, QT prolongation

— Cardiac arrest, often peri-intubation

— Severe anion gap metabolic acidosis

— Hypokalemia (renal losses during alkalinization)

— Hypoglycemia and CNS neuroglycopenia

— Hyperthermia from uncoupling — can mimic sepsis or NMS

— Dehydration, prerenal AKI

— Platelet dysfunction → bleeding

— Hypoprothrombinemia (decreased factor VII) → elevated INR

— Hemorrhagic gastritis, GI bleeding

— Pulmonary edema from over-resuscitation with bicarbonate-containing fluids

— Hypernatremia from bicarbonate

— Worsened acidosis if acetazolamide given (contraindicated)

— Catastrophic deterioration from inappropriate intubation/under-ventilation

— Late presentation

— Acidemia (pH <7.20)

— CNS depression on arrival

— Chronic vs acute

— Need for intubation

— Age >70

Neurologic:

Pulmonary:

Cardiovascular:

Metabolic:

Hematologic/GI:

Iatrogenic complications:

Mortality predictors:

Board pearl: ARDS and cerebral edema in a salicylate-poisoned patient are dialysis-mandatory complications. Don't keep treating with more fluids and bicarbonate — call nephrology immediately.

CCS pearl: Anticipate and document each complication's monitoring: cardiac monitor, pulse ox, frequent neuro exam, urine output, serial labs. The CCS rewards proactive surveillance.

When to Escalate — ICU, Consults, and Inpatient Triage

— Altered mental status, seizure, coma

— pH <7.30 or rapidly falling

— Salicylate level >80 acute or >60 chronic

— Hemodynamic instability, vasopressor need

— Pulmonary edema/ARDS or hypoxia requiring supplemental O2

— Renal failure or oliguria

— Receiving or pending hemodialysis

— Intubated or at high risk of intubation

— Symptomatic but mentally intact

— Level 40–80 acute, stable trend

— Receiving bicarbonate infusion

— Stable acid-base, normal renal function

— Asymptomatic, level <40, falling, normal labs, alert

— Minimum 6 h observation post-ingestion if regular-release; 24 h or longer for enteric-coated/sustained-release

— Poison Control (1-800-222-1222) — call early; expert guidance and case tracking

— Medical toxicology — bedside if available

— Nephrology — for any patient meeting or approaching EXTRIP criteria; do not wait

— Psychiatry — all intentional ingestions, before discharge planning

— OB — pregnant patients

— ICU/critical care — early in severe cases

— Facility without HD capability + patient meeting criteria → transfer emergently with bicarbonate infusion running, accepting nephrologist and ICU bed confirmed

— Stable patients on alkalinization can remain at non-HD facility with close monitoring and pre-arranged transfer plan

— Two consecutive declining levels reaching <30 mg/dL

— Resolution of symptoms, normal acid-base

— Psychiatric clearance if intentional

— Confirmed safe medication reconciliation if chronic

ICU admission criteria:

Step-down/monitored bed:

Floor/observation:

Consults to call:

Transfer considerations:

Discharge from ED requires:

Step 3 management: For any intentional ingestion, document suicide risk assessment, place patient in safe environment (sitter, removal of belongings), and obtain psych eval before medical clearance. Medical stability ≠ disposition readiness.

CCS pearl: "Update final diagnoses, sign psych consult, ensure follow-up arranged" before ending the case — these closure steps score.

Key Differentials — Same-Category Toxicologic Causes

— Methanol — visual disturbance ("snowfield"), optic disc hyperemia, fundoscopic abnormalities, elevated osmolar gap; treat with fomepizole + HD

— Uremia — chronic kidney failure, elevated BUN/Cr, no respiratory alkalosis

— DKA — hyperglycemia, ketonemia, history of T1DM; no tinnitus, no respiratory alkalosis (Kussmaul is compensatory only)

— Propylene glycol — lorazepam/phenobarbital infusion in ICU

— Iron, Isoniazid (INH) — INH causes refractory seizures responsive to pyridoxine

— Lactic acidosis — sepsis, ischemia, metformin; check lactate

— Ethylene glycol — oxalate crystals in urine, AKI, calcium oxalate, hypocalcemia

— Starvation, Salicylates

— Mixed respiratory alkalosis + AGMA — almost unique to salicylates (sepsis can mimic but lacks tinnitus, hypoglycemia, characteristic history)

— Tinnitus, hyperthermia, diaphoresis

— Normal or elevated pH early

— Osmolar gap >10 raises suspicion for methanol/ethylene glycol

— Salicylates do not cause osmolar gap

— Always check APAP level; combined ASA/APAP products exist

— APAP toxicity is later (24–72 h hepatic) and treated with NAC

— Ibuprofen massive overdose can cause AGMA and seizures but lacks classic respiratory alkalosis and tinnitus

— Cocaine, amphetamines, MDMA — hyperthermia and agitation but no tinnitus, normal acid-base or mild lactic

— Serotonin syndrome — clonus, hyperreflexia, recent SSRI/MAOI

Other causes of anion-gap metabolic acidosis (MUDPILES):

How salicylate differs:

Toxic alcohols quick screen:

Acetaminophen co-ingestion:

Other analgesic/NSAID toxicity:

Sympathomimetic/serotonergic overdoses:

Board pearl: Salicylates and toxic alcohols are the two MUDPILES causes where time-to-antidote/dialysis directly determines survival. Aggressive early intervention is graded.

Key distinction: Salicylate has mixed acid-base disturbance with respiratory alkalosis as primary — methanol, ethylene glycol, DKA, lactic acidosis all show isolated metabolic acidosis with appropriate compensation.

Key Differentials — Other-Category Causes

— Fever, tachypnea, tachycardia, altered mentation, lactic acidosis — overlaps significantly with chronic salicylism

— Distinguish: tinnitus, history of ASA, mixed acid-base with primary respiratory alkalosis, salicylate level

— In elderly patients labeled "septic" who don't improve on antibiotics, send a salicylate level

— Hyperglycemia, ketonuria, fruity breath, polyuria/polydipsia history

— Pure AGMA, not mixed; no tinnitus

— Hyperthermia, tachycardia, agitation, hyperventilation

— Look for goiter, ophthalmopathy, AF, TFTs

— Pearl: salicylates can precipitate thyroid storm in hyperthyroid patients by displacing T4 from TBG

— Fever, altered mentation, meningismus, photophobia

— LP if suspected; salicylate testing in parallel

— Environmental history, core temp >40°C, anhidrosis (classic) or exertional history

— May coexist with salicylates (uncoupling drives hyperthermia)

— Asterixis, jaundice, ascites, elevated NH3

— Respiratory alkalosis present but not with AGMA from salicylates

— Focal deficits, sudden onset, head CT abnormal

— Tachypnea, hypoxia, respiratory alkalosis — but no AGMA, no tinnitus

— Hyperventilation with respiratory alkalosis but normal AG, no metabolic acidosis, no tinnitus, no fever

— Encephalopathy + hepatic dysfunction after viral illness with ASA use — historic but boards-relevant

Sepsis:

Diabetic ketoacidosis:

Thyroid storm:

CNS infection (meningitis, encephalitis):

Heatstroke:

Hepatic encephalopathy:

Stroke/intracranial process:

Pulmonary embolism:

Anxiety/panic attack:

Reye syndrome (pediatric):

Step 3 management: When the differential is broad, the ABG + AG + salicylate level efficiently includes or excludes salicylism in <1 h — order them on any hyperventilating, confused, or acidotic patient with ASA exposure or unclear history.

Board pearl: Three classic chronic-salicylism mimics on the exam: sepsis in the elderly, dementia/delirium workup, "atypical" CHF exacerbation. Always check the medication list.

Secondary Prevention, Discharge Medications, Long-Term Plan

— Stop or replace chronic ASA in patients who developed chronic toxicity from therapeutic dosing — consider clopidogrel for secondary CV prevention if ASA implicated and intolerance demonstrated

— Reassess indication for ASA in primary prevention — USPSTF 2022: shared decision-making 40–59, generally not recommended ≥60 for primary prevention

— Discontinue concomitant NSAIDs, identify drug interactions

— Review all OTC products containing salicylates: Pepto-Bismol, oil of wintergreen, topical analgesics (BenGay, IcyHot, Aspercreme), effervescent ASA antacids, salicylate-containing herbals (willow bark)

— Maximum daily ASA dose, signs of toxicity (tinnitus, nausea, confusion)

— Avoid combining multiple salicylate-containing products

— Hydrate during illness; pause ASA during gastroenteritis/dehydration

— In children: no aspirin for viral illness (Reye syndrome); use acetaminophen or ibuprofen instead

— Avoid concurrent NSAID + ACEi/ARB + diuretic (triple whammy)

— Annual renal function monitoring in chronic ASA users

— Outpatient psychiatry within 1 week

— Means restriction counseling (lock up medications, limit quantities dispensed)

— Safety plan documented in chart

— Consider SSRI initiation if untreated depression — but coordinate with psychiatry

— Substance use evaluation if applicable

— Pill counts, blister packs, or family-managed dispensing for high-risk patients

— Avoid prescribing combination products (e.g., Excedrin) to those with prior overdose

Medication reconciliation at discharge:

Patient and caregiver education:

Renal protection:

Intentional ingestion follow-up:

Pharmacy and prescribing safeguards:

Step 3 management: Discharge order set: medication list with explicit "stop" and "continue" lines, outpatient PCP follow-up within 1 week, psychiatry referral if intentional, written instructions, return precautions for tinnitus/confusion/persistent vomiting.

Board pearl: USPSTF no longer routinely recommends aspirin for primary cardiovascular prevention in adults ≥60 — a frequent Step 3 stem leading to deprescribing.

Follow-Up, Monitoring, and Counseling

— Salicylate level q2h until consistently <30 mg/dL and falling

— BMP q4–6h until acid-base normal and K+ stable

— Urine pH q1h while on bicarbonate

— Continuous cardiac and pulse oximetry

— Hourly neuro checks until mental status normal

— Strict I/O, daily weights

— Asymptomatic, normal mental status

— Salicylate level <30 and trending down on two consecutive draws

— Resolved acid-base disturbance

— Normal renal function or baseline

— Tolerating PO

— Psychiatric clearance if intentional ingestion

— Safe disposition (no unsupervised access if cognitively impaired)

— PCP within 1 week for medication review, renal function check

— Audiology evaluation if persistent tinnitus or hearing changes

— Psychiatry within 1 week for intentional ingestion; sooner if active suicidality

— Geriatrics consult for elderly with chronic toxicity to optimize polypharmacy

— Recognize early symptoms: ringing in ears, nausea, rapid breathing — stop the medication and call provider

— Avoid wintergreen oil, especially around children

— Read OTC labels for salicylate content

— Heatstroke and dehydration increase risk; hydrate during exercise and illness

— Family or aide should administer medications

— Use pillboxes, blister packs

— Maintain accurate medication list at every visit

— Cognitive rehab if persistent encephalopathy

— Pulmonary rehab if ARDS sequelae

— Hearing aids if permanent ototoxicity

Inpatient monitoring until disposition:

Discharge criteria:

Outpatient follow-up:

Counseling content:

Caregiver education for cognitively impaired elderly:

Rehabilitation considerations:

Step 3 management: Document teach-back at discharge — patient or caregiver verbalizes warning signs and action plan. Provide written instructions and Poison Control number.

CCS pearl: Order "PCP follow-up in 1 week, psychiatry follow-up in 1 week, return precautions" explicitly — these closure orders count in the simulation.

Ethical, Legal, and Patient Safety Considerations

— Assume lack of decisional capacity during acute toxicity (encephalopathy from salicylates impairs judgment)

— Treat under implied/emergency consent — life-threatening overdose

— A patient who refuses bicarbonate or dialysis while encephalopathic does not have capacity; document a formal capacity assessment by the treating physician (orientation, understanding, appreciation, reasoning, choice expression)

— Engage family/surrogate; involve ethics consult if capacity disputed in marginal cases

— Patients presenting after intentional overdose typically meet criteria for involuntary psychiatric hold (state-specific: 5150, Section 12, etc.) pending evaluation

— 1:1 sitter, remove belongings, search for additional pills

— Document suicide risk assessment with explicit risk factors and plan

— Pediatric ingestion: assess for neglect/abuse, especially recurrent or developmentally implausible ingestions — Child Protective Services report when indicated

— Elder ingestion: if caregiver provided incorrect doses or there is suspicion of intentional harm or self-neglect, Adult Protective Services notification

— Munchausen by proxy: recurrent unexplained pediatric salicylism warrants investigation

— Many chronic toxicity cases involve double-dosing, OTC stacking, or transcription errors at care transitions (hospital→SNF, home health changes)

— Mandatory medication reconciliation at every transition; root-cause analysis for institutional events

— Discharging an elderly patient on multiple analgesics without explicit caregiver instruction is a high-yield Step 3 safety failure

— Use teach-back, written instructions, follow-up call within 48–72 h

— Adolescent intentional ingestion: balance confidentiality with parental notification — typically parents must be informed for safety planning; document

— Encephalopathic patient → emergency/implied consent; engage next of kin when feasible but do not delay life-saving therapy

Intentional ingestion and capacity:

Psychiatric hold:

Mandatory reporting:

Medication safety/error:

Transition-of-care risk:

Confidentiality:

Informed consent for hemodialysis:

Board pearl: "Acute encephalopathy from the poisoning itself eliminates capacity to refuse antidotal therapy" — proceed with life-saving treatment and document.

Step 3 management: Always document capacity, suicide risk, safety plan, and follow-up on discharge — these are graded patient-safety domains.

High-Yield Associations and Rapid-Fire Facts

Toxic dose: acute >150 mg/kg; severe >300 mg/kg; lethal >500 mg/kg

One teaspoon oil of wintergreen ≈ 7 g aspirin ≈ 21 adult tablets — lethal to a toddler

Therapeutic level 10–30 mg/dL; toxic >40; severe >80 acute or >60 chronic

Classic acid-base: mixed primary respiratory alkalosis + anion gap metabolic acidosis (adults); pure AGMA in children/late

Tinnitus correlates with levels >30 mg/dL

Done nomogram: historically useful, not recommended today — use clinical picture and trends

Urine pH goal: 7.5–8.0; serum pH goal: 7.45–7.55

Bicarbonate recipe: 3 amps NaHCO3 + 40 mEq KCl in 1 L D5W at 1.5–2× maintenance

Hypokalemia prevents urinary alkalinization — always repletes K+ to ≥4

Acetazolamide is contraindicated — worsens systemic acidosis

HD indications (EXTRIP): AMS, ARDS, cerebral edema, renal failure, pH ≤7.20, level >100 acute or >90 with AKI, chronic >60 symptomatic, failure of supportive therapy

Avoid intubation when possible; if required, match pre-intubation minute ventilation

Salicylate properties favorable for HD: small MW (138 Da), low Vd (0.2 L/kg), low protein binding at high levels

Reye syndrome: ASA in viral illness (varicella, influenza) in children → encephalopathy + hepatic failure

Kawasaki disease: the one exception allowing ASA in children

Chronic toxicity in elderly = higher mortality, lower level threshold, mimics sepsis

Pregnant patients: fetal levels exceed maternal; lower HD threshold; risk of premature ductal closure

Bismuth subsalicylate (Pepto-Bismol) and topical methyl salicylate are underrecognized exposures

Co-ingestion screen: always check acetaminophen in intentional overdose

Hypoglycemia: check fingerstick on arrival; treat empirically if AMS

Hyperthermia = uncoupling oxidative phosphorylation; ominous

USPSTF 2022: routine ASA primary CV prevention not recommended ≥60

Pharmacobezoar with enteric-coated ASA → rising levels despite treatment → whole-bowel irrigation, MDAC, possibly repeat HD

Board pearl: When in doubt — alkalinize, replete potassium, monitor, and call nephrology.

Board Question Stem Patterns

— Diagnosis: acute salicylate toxicity

— Next steps: activated charcoal, bicarbonate infusion, serial levels, K+ repletion, APAP level, psychiatry consult

— Trap: do not intubate prophylactically

— Diagnosis: chronic salicylate toxicity

— Action: hemodialysis — symptomatic chronic level >60 threshold approached, AMS present

— Trap: assuming sepsis and giving fluids/antibiotics only

— Diagnosis: methyl salicylate toxicity

— Action: dextrose, bicarbonate, early HD, ICU

— Trap: low salicylate level threshold missed

— Lesson: must match pre-intubation minute ventilation; bicarbonate push pre/peri-RSI; emergent HD

— Patient safety theme

Stem 1 — Classic acute adolescent overdose: 16-year-old after argument, found with empty ASA bottle, tinnitus, vomiting, RR 32, ABG pH 7.46 / PaCO2 22 / HCO3 16, AG 22.

Stem 2 — Elderly chronic toxicity masquerading as sepsis: 78-year-old on ASA for AF, recent UTI on TMP-SMX, now confused, tachypneic, T 38.4, level 55, pH 7.32.

Stem 3 — Pediatric wintergreen ingestion: 2-year-old, vomiting, hyperpnea, glucose 45, pH 7.18, AG 24.

Stem 4 — Peri-intubation deterioration: Salicylate patient intubated for "respiratory fatigue," set to RR 12, pH crashes to 7.05, cardiac arrest.

Stem 5 — Mixed acid-base recognition: ABG with primary respiratory alkalosis and AGMA — question asks diagnosis → salicylate

Stem 6 — Bicarbonate not working: Urine pH stuck at 6.5 despite bicarbonate infusion → check and replete potassium

Stem 7 — Sustained-release pitfall: Initial level 30 at 2 h, patient feels better — but enteric-coated ingestion; level rises to 80 at 12 h → continue serial levels, do not discharge early

Stem 8 — Acetazolamide trap: Patient with glaucoma + ASA toxicity → do not give acetazolamide

Stem 9 — Pregnancy: 28 weeks pregnant, salicylate level 75, mild confusion → HD plus OB consult and fetal monitoring

Stem 10 — Discharge planning: Recovered intentional overdose → psychiatric clearance, means restriction, follow-up scheduled before discharge

Board pearl: The question's hardest pivot is usually "which intervention next?" — if the patient has AMS, acidemia, or end-organ involvement, the answer is hemodialysis, not more bicarbonate.

One-Line Recap

Salicylate toxicity is the mixed respiratory-alkalosis-plus-anion-gap-metabolic-acidosis syndrome whose management hinges on early recognition (especially of chronic toxicity in elderly), aggressive sodium bicarbonate with potassium repletion to alkalinize serum and urine, and emergent hemodialysis for altered mental status, severe acidemia, pulmonary or cerebral edema, renal failure, or refractory levels.

Recognize: tinnitus + hyperpnea + mixed acid-base = salicylates; chronic toxicity in elderly mimics sepsis and kills at "low" levels (40–60 mg/dL).

Treat first-line: isotonic fluid resuscitation, NaHCO3 infusion (3 amps in 1 L D5W + 40 mEq KCl at 1.5–2× maintenance) targeting serum pH 7.45–7.55 and urine pH 7.5–8.0; activated charcoal if early and airway protected; replete K+ to ≥4; check acetaminophen level and glucose.

Dialyze for EXTRIP criteria: altered mental status, ARDS, cerebral edema, renal failure, pH ≤7.20, acute level >100 (>90 with AKI), chronic >60 with symptoms, or failure of supportive care; intermittent HD preferred and may need a second run for rebound.

Avoid pitfalls: never give acetazolamide; avoid intubation when possible and match pre-intubation minute ventilation if unavoidable; serial levels for enteric-coated/sustained-release; always assess capacity and arrange psychiatric follow-up for intentional ingestion before discharge.

Step 3 management: Disposition is driven by trajectory and end-organ status, not absolute level — when in doubt, alkalinize, monitor closely, and call nephrology early. CCS pearl: order set must include serial salicylate levels, q1h urine pH, q4h BMP, continuous monitoring, Foley, psychiatry consult, and follow-up scheduling for full credit on closure.